Results for Query ‹ Familial partial lipodystrophy associated with LIPE mutations medication

Congenital generalized lipodystrophy – Treatment

Congenital generalized lipodystrophy – Treatment | Diet

Lipodystrophy – Antiretroviral drugs

Lipodystrophy – Insulin injections

Acquired generalized lipodystrophy – Treatment and prognosis

HIV-associated lipodystrophy – Prognosis

HIV-associated lipodystrophy – Management

Barraquer–Simons syndrome – Treatment

Familial hypercholesterolemia – Treatment | Homozygous FH

Cantú syndrome – Treatment

Familial hypercholesterolemia – Treatment | Heterozygous FH

Lecithin cholesterol acyltransferase deficiency – Treatment

MDP syndrome – Management | General

Hereditary sensory and autonomic neuropathy type I – Management

MDP syndrome – Management | Lipodystrophy | Management of lipodystrophy

Laminopathy – Treatment and drug development

Acquired generalized lipodystrophy – Recent research

Hereditary sensory and autonomic neuropathy type I – Management | Genetic counseling

Von Hippel–Lindau disease – Treatment

Hyper-IgD syndrome – Treatment

Dysfibrinogenemia – Acquired dysfibrinogenemia | Treatment

Marfan syndrome – Management | Medications

Metabolic syndrome – Management

Familial dysautonomia – Treatment | Treatment of manifestations

Familial dysautonomia – Treatment